Nishihara Reiko, Wang Molin, Qian Zhi Rong, Baba Yoshifumi, Yamauchi Mai, Mima Kosuke, Sukawa Yasutaka, Kim Sun A, Inamura Kentaro, Zhang Xuehong, Wu Kana, Giovannucci Edward L, Chan Andrew T, Fuchs Charles S, Ogino Shuji, Schernhammer Eva S
From the Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA (RN, ZRQ, MY, KM, YS, SAK, KI, CSF, and SO); the Departments of Nutrition (RN, KW, and ELG), Epidemiology (MW, ELG, SO, and ESS), and Biostatistics (MW), Harvard School of Public Health, Boston, MA; the Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA (MW, XZ, KW, ELG, ATC, CSF, and ESS); the Department of Gastroenterological Surgery, Graduate School of Medical Science, Kumamoto University, Kumamoto, Japan (YB); the Division of Gastroenterology, Massachusetts General Hospital, Boston, MA (ATC); and Applied Cancer Research-Institution for Translational Research Vienna, Vienna, Austria (ESS).
Am J Clin Nutr. 2014 Dec;100(6):1479-88. doi: 10.3945/ajcn.114.095539. Epub 2014 Oct 8.
Although a higher consumption of alcohol, which is a methyl-group antagonist, was previously associated with colorectal cancer risk, mechanisms remain poorly understood.
We hypothesized that excess alcohol consumption might increase risk of colorectal carcinoma with hypomethylation of insulin-like growth factor 2 (IGF2) differentially methylated region-0 (DMR0), which was previously associated with a worse prognosis.
With the use of a molecular pathologic epidemiology database in 2 prospective cohort studies, the Nurses' Health Study and Health Professionals Follow-up Study, we examined the association between alcohol intake and incident colorectal cancer according to the tumor methylation level of IGF2 DMR0. Duplication-method Cox proportional cause-specific hazards regression for competing risk data were used to compute HRs and 95% CIs. In addition, we investigated intakes of vitamin B-6, vitamin B-12, methionine, and folate as exposures.
During 3,206,985 person-years of follow-up, we identified 993 rectal and colon cancer cases with an available tumor DNA methylation status. Compared with no alcohol consumption, the consumption of ≥15 g alcohol/d was associated with elevated risk of colorectal cancer with lower levels of IGF2 DMR0 methylation [within the first and second quartiles: HRs of 1.55 (95% CI: 1.08, 2.24) and 2.11 (95% CI: 1.44, 3.07), respectively]. By contrast, alcohol consumption was not associated with cancer with higher levels of IGF2 DMR0 methylation. The association between alcohol and cancer risk differed significantly by IGF2 DMR0 methylation level (P-heterogeneity = 0.006). The association of vitamin B-6, vitamin B-12, and folate intakes with cancer risk did not significantly differ according to IGF2 DMR0 methylation level (P-heterogeneity > 0.2).
Higher alcohol consumption was associated with risk of colorectal cancer with IGF2 DMR0 hypomethylation but not risk of cancer with high-level IGF2 DMR0 methylation. The association between alcohol intake and colorectal cancer risk may differ by tumor epigenetic features.
尽管先前已发现作为甲基基团拮抗剂的酒精摄入量增加与结直肠癌风险相关,但其机制仍知之甚少。
我们推测过量饮酒可能会增加胰岛素样生长因子2(IGF2)差异甲基化区域0(DMR0)低甲基化的结直肠癌风险,该区域先前与较差的预后相关。
利用两项前瞻性队列研究(护士健康研究和卫生专业人员随访研究)中的分子病理流行病学数据库,我们根据IGF2 DMR0的肿瘤甲基化水平研究了酒精摄入量与结直肠癌发病之间的关联。采用重复法Cox比例病因特异性风险回归分析竞争风险数据,以计算风险比(HR)和95%置信区间(CI)。此外,我们还将维生素B-6、维生素B-12、蛋氨酸和叶酸的摄入量作为暴露因素进行了研究。
在3206985人年的随访期间,我们确定了993例可获得肿瘤DNA甲基化状态的直肠癌和结肠癌病例。与不饮酒相比,每天饮用≥15克酒精与IGF2 DMR0甲基化水平较低的结直肠癌风险升高相关[在第一和第二四分位数内:HR分别为1.55(95%CI:1.08,2.24)和2.11(95%CI:1.44,3.07)]。相比之下,饮酒与IGF2 DMR0甲基化水平较高的癌症无关。酒精与癌症风险之间的关联因IGF2 DMR0甲基化水平而有显著差异(P异质性 = 0.006)。维生素B-6、维生素B-12和叶酸摄入量与癌症风险之间的关联根据IGF2 DMR0甲基化水平无显著差异(P异质性 > 0.2)。
较高的酒精摄入量与IGF2 DMR0低甲基化的结直肠癌风险相关,但与IGF2 DMR0高甲基化的癌症风险无关。酒精摄入量与结直肠癌风险之间的关联可能因肿瘤表观遗传特征而异。